{
  "actions": [
    {
      "acted_at": "2021-12-07",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2021-12-07",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2021-12-07",
      "action_code": "H11100",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2021-12-08",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2022-11-01",
      "action_code": "",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6150-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU",
      "subcommittee": "Subcommittee on Crime and Federal Government Surveillance",
      "subcommittee_id": "08"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "F000466",
      "district": "1",
      "name": "Fitzpatrick, Brian K.",
      "original_cosponsor": true,
      "sponsored_at": "2021-12-07",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001196",
      "district": "6",
      "name": "Moulton, Seth",
      "original_cosponsor": true,
      "sponsored_at": "2021-12-07",
      "state": "MA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-12-07",
  "number": "6150",
  "official_title": "To amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s3327-117",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Opioid QuOTA Act of 2021",
  "sponsor": {
    "bioguide_id": "C001084",
    "district": "1",
    "name": "Cicilline, David N.",
    "state": "RI",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-12-07",
  "subjects": [
    "Crime and law enforcement",
    "Drug trafficking and controlled substances",
    "Drug, alcohol, tobacco use",
    "Health programs administration and funding"
  ],
  "subjects_top_term": "Crime and law enforcement",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2021-12-07",
    "date": "2022-01-14T10:43:59Z",
    "text": "Opioid Quota Openness, Transparency, and Awareness Act of 2021 or the Opioid QuOTA Act of 2021\n\nThis bill requires the Drug Enforcement Administration to make publicly available on its website certain information regarding opioid procurement quotas.\n\nThe term opioid procurement quota means the maximum quantity of opioid analgesics that a registered manufacturer may procure."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Opioid QuOTA Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Opioid QuOTA Act of 2021",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Opioid Quota Openness, Transparency, and Awareness Act of 2021",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2023-05-15T17:15:21Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr6150.xml"
}